Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

I have a hard time following your "opinions" at times.

55

The June DMT stroke PR was made Before the Ifenprodil Dartmoth research was known or the even more recent 'interim' IPF/CC data 'trends'.

AND?

55

See "FORWARD LOOKING STATEMENT"...

Yes, management can blow smoke up our ass-ets.

Also, "FORWARD LOOKING INFORMATION" states:

"the Company’s directors may have conflicts of interest"

Answeer me this. Just because it's written in black and white, does that mean it's ok? What do you actually thyink about the known conflicts of interests that continue at Algernon regardless to whom is in charge at Algernon?

We know beer buddy has engaged in immoral acts as CEO and nepotism as CEO at his prior gig.

Do you find any of what you know as immoral at best or potentially illegal?

55

Now some math? I am assuming the CEO would want a R/S of 1/10 as compared to 1/50.

What brings you to that "assumption"? Might it be after having a few beers with beer buddy? Otherwise, what we have to go on as facts is what the current share price is as of now in relationship to a reverse split to uplist. I'm not making assumptions about 1 for 50. That's simply real world math. If you know something more, how about spilling the beans versus the mumbo jumbo assumptions...

55

News about the Ifenprodil 'Indications" AGN is pursuing will precede news about the psyc angle. IMO.

This is most confusing. What exact "indications" are you talking about that will happen before the DMT/Stroke clinical trial? If DMT is the first thing out the gate towards a data readout, I'm not understanding what it is you believe will happen before that?

55

I am invested/hope/predict for positive meeting results and approvals of All the current FDA and MNRA applications.

No brainer. FDA & MHRA will approve a ham sandwich study for reducing love handles. It's your money not theirs. They get paid no matter what the results. JUST LIKE MANAGEMENT & BOARD OF DIRECTORS @ ALGERNON PHARMACEUTICALS INC.

55

Properly handled AGN could avoid a R/S and have a minimal dilution Private Placement. Maybe...

What I obviously fail to understand is the belief an uplisting to NASDAQ is not seriously in the cards for Algernon in it's supposed efforts to align itself with bigger pockets to throw money at the cause. What I'm hearing you say is management has no serious intention to uplist. They just threw that into the PR to scare the bejesus out of people like me who can do math? People who know a reverse split even at 1 for 10 before dollarsville will be self destructive for shareholders. I don't care how a reverse split is packaged up and explained. Even Christopher Moreau conceded to me directly that reverse splits do not go well for those holding shares - FACT. Hence, you will be forced to sell at whatever price pre-reverse split. There goes my long term position and minimal capital gains tax up in flames. Please forgive me...I do real world math.

Oh! One other thing to consider from the latest PR:

"...recently received a CAD$2M cash payment from a refundable tax credit program from its clinical research work in Australia, which brings Algernon’s current working capital balance to approximately CAD$3.5M."

If Algernon received a $2M CAD refund for a 20 PARTICIPANT clinical study, how many people do you think will be needed to participate in a Phase 1 study for stroke and Cancer? Did the CEO ever tell the market the cost of either one of those Phase 1 studies? Do you or anyone reading this know? It would be helpful. That would tell us Egg Zack Lee how cash strapped Algernon is heading towards multiple clinical trials. Common sense tells me there's cash needed ASAP.

M$